Infectious Diseases 5: In utero exposures and infections

Infectious Diseases 5: In utero exposures and infections

031 - Incidence of Influenza-Associated Serious Neurologic Events in Young Children

032 - The Australasian Congenital Cytomegalovirus (cCMV) Register: outcomes of children with cCMV in Australia

033 - Serum Proteomic Signatures in Children Exposed to Antenatal SARS CoV-2: Associations with Positive Autism Spectrum Disorder (ASD) Screening in a Longitudinal Cohort

034 - Challenges in Addressing Congenital Syphilis in a Large Hospital System

035 - Maternal gut microbiota-derived EVs form a distinct taxonomic entity during pregnancy

036 - The Role of IL-9 Signaling in Immune-Mediated Preterm Birth

037 - Increasing Testing for Congenital Cytomegalovirus Infection in Newborns with Sensorineural Hearing Loss: A Quality Improvement Project.

038 - Rotavirus Vaccine Responses as a Function of Infant Gut Microbiome and Breastmilk Exposure.

039 - The Impact of Symptomatic Maternal SARS-CoV-2 Symptoms and Treatment on the Need for Delivery Room Resuscitation in Preterm Infants

040 - “It made me feel like I was going to be okay…[but] is a daily reminder that I have HIV“ Perspectives on Treatment Needs of Youth with HIV from the Biktarvy Outcomes in Baltimore Youth Study (B.O.B.Y)

041 - Evaluating the Characteristics and Impact of Youth-Friendly Services on Viral Suppression for Youth with HIV in Ryan White Clinics

042 - No differences in T&B cell populations before influenza vaccine in adolescents with Crohn Disease, but do they respond adequately?

043 - Uptake of Nirsevimab in Infants Aged 0-12 Months in San Diego County During the 2023-2024 RSV Season

044 - Characterizing a Cohort of Infants Born to Mothers with Syphilis During Pregnancy

045 - Implementation of Targeted and Expanded Congenital CMV Screening in the NICU Using Saliva Polymerase Chain Reaction